Status:
COMPLETED
Serum Resistin Level Following Non-surgical Periodontal Therapy in Diabetic Patients With Chronic Periodontitis
Lead Sponsor:
Cairo University
Conditions:
Type2 Diabetes
Eligibility:
All Genders
40-55 years
Phase:
NA
Brief Summary
non-surgical periodontal debridement was performed for diabetic patients with chronic periodontitis as well as for non-diabetic patients but also with chronic periodontitis. Serum resistin level was a...
Detailed Description
Background: Resisitin is a recognized marker for chronic inflammatory conditions that could be directly linked with type 2 diabetes mellitus. The aim of this study was to assess serum resistin level i...
Eligibility Criteria
Inclusion
- diagnosed with moderate to severe chronic periodontitis.
- Presence of a minimum of 15 natural teeth
- Presence of at least four teeth with one or more sites with probing pocket depth (PPD) ≥5mm and clinical attachment level (CAL) ≥4mm
- agreement to participate in the study and sign a written informed consent
Exclusion
- Patients who received any periodontal treatment or professional scaling and root planing of the teeth for at least 6 months prior to the study initiation
- A history of antibiotics therapy and anti-inflammatory drugs within the previous 6 months
- Pregnancy or use of contraceptives or any medication related to diabetes
- former or current smokers ˂ 5 years.
Key Trial Info
Start Date :
September 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 30 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04473209
Start Date
September 1 2018
End Date
January 30 2020
Last Update
July 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 11865